Recombinant Anti-CCR3 x Anti-CD300 Bispecific Antibody (Tandem scFv)  (BSFV-028)

Recombinant Anti-CCR3 x Anti-CD300 Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-CCR3 antibody variable domains fused with a scFv from an anti-CD300 antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb canreduce eosinophil signaling, inhibit bronchoalveolar lavage fluid inflammation, eosinophil, mast cell mediator release and reverse lung inflammation. It is designed for the research of Asthma therapy.

Datasheet